The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Plasma Cell Dyscrasia Comprehensive Overview

Spectrum from MGUS to multiple myeloma in plasma cell disorders

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Plasma Cell Dyscrasia Comprehensive Overview?

Plasma cell dyscrasias are clonal proliferations of plasma cells producing monoclonal immunoglobulin protein. The spectrum ranges from monoclonal gammopathy of undetermined significance through smoldering myeloma to symptomatic multiple myeloma. Each entity has distinct diagnostic criteria and treatment implications.

MGUS is defined by serum monoclonal protein under three grams per deciliter clonal plasma cells under ten percent and absence of end organ damage with progression risk approximately one percent yearly. Smoldering myeloma has higher tumor burden but no end organ damage. Multiple myeloma requires CRAB criteria of hypercalcemia renal failure anemia or bone lesions.

Other plasma cell dyscrasias include AL amyloidosis with light chain deposition causing organ dysfunction Waldenstrom with IgM monoclonal gammopathy and lymphoplasmacytic infiltrate POEMS syndrome and solitary plasmacytoma. Initial workup includes serum and urine protein electrophoresis immunofixation free light chains skeletal survey and bone marrow examination.

Symptoms

Bone pain and pathologic fractures in myeloma
Anemia fatigue and weakness
Hypercalcemia symptoms confusion thirst
Renal dysfunction with proteinuria
Recurrent infections from immunoparesis

Risk Factors

Age over fifty years
Male sex and African ancestry
Family history of plasma cell disorder
Exposure to ionizing radiation
Preceding MGUS or smoldering myeloma

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When monoclonal protein is detected
  • When unexplained anemia or renal failure occurs
  • When bone pain or fractures appear
  • When hypercalcemia is identified

Treatment Methods

01
Serum and urine protein electrophoresis with immunofixation
02
Free light chain ratio measurement
03
Skeletal survey or whole body imaging
04
Bone marrow biopsy with cytogenetics
05
Risk stratification and treatment by entity
06
Hematology referral for management decisions

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.